Jinsheng Hao

Jinsheng Hao

Auto-generated profile, based on publicly available information

Jinsheng Hao

National Center for children's Health, Beijing, People's Republic of China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2019 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
JHJinsheng Hao
Jinsheng Hao
MCMin Chen
Min Chen
BLBing Liu
Bing Liu
YYYang Yang
Yang Yang
WLWei Liu
Wei Liu
JZJie Zhang
Jie Zhang

1 September 2018 in Pediatric Investigation
Verified
Journal Article
Open access
PDF file
WLWei Liu
Wei Liu
BLBing Liu
Bing Liu
MCMin Chen
Min Chen
JHJinsheng Hao
Jinsheng Hao
YYYang Yang
Yang Yang
JZJie Zhang
Jie Zhang
Importance: First branchial cleft anomaly (FBCA) is a rare disease that is difficult to diagnose and is associated with a high rate of complications. However, the difference between two types of FBCA and how to avoid complications are not clear enough.Objective: We retrospectively analyzed type I and II (Work's classification) FBCAs in children to demonstrate the difference between the two types of FBCAs, especially with respect to understanding the relationship between FBCAs and the facial nerveMethods: We retrospectively reviewed patients with FBCAs who were treated in Beijing Children's Hospital from 2013 to 2017. The patients’ clinical data, relationship of the FBCA with the facial nerve, and postoperative complications were recorded.Results: The study included 70 patients with FBCAs. In total, 41 (58.6%) patients had a type I FBCA, and 29 (41.1%) had a type II FBCA. A cystic mass was present in 34 (48.6%) patients. Sixty‐two (88.6%) patients had a history of incision and drainage and nine (12.8%) had a history of excision surgery in other hospitals. The accuracy rate of magnetic resonance imaging was higher than ultrasound and much higher than computed tomography. Thirty‐eight (92.7%) type I FBCAs had no close relationship with the facial nerve. The facial nerve in 14 (48.3%) patients with type II FBCAs was located superficial to and above the mass. Fifteen (51.7%) type II facial nerves were located on the deep side of the mass. All patients in the study had an abnormal external auditory canal (EAC). Three patients had temporary facial palsy that resolved within one week. Eleven patients with type I FBCAs had mild EAC stenosis. No recurrence was observed.Interpretation: Type II FBCAs had a close relationship with the facial nerve, especially when the lesion was located in the mandible angle. All patients with FBCAs had an EAC abnormality. The abnormal skin and cartilage of the EAC should be excised together to avoid recurrence.

14 January 2016 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
PDF file
SHShujing Han
Shujing Han
XYXiaojian Yang
Xiaojian Yang
Yi ZhouYi Zhou
Yi Zhou
JHJinsheng Hao
Jinsheng Hao
ASAdong Shen
Adong Shen
XNXin Ni
Xin Ni
Objective To determine the incidence of congenital hearing loss (HL) in newborns by the rate of deafness-related genetic mutations. Design Clinical study of consecutive newborns in Beijing using allele-specific polymerase chain reaction-based universal array. Study sample This study tested 37 573 newborns within 3 days after birth, including nine sites in four genes: GJB2 (35 del G, 176 del 16, 235 del C, 299 del AT), SLC26A4 (IVS7-2 A > G, 2168 A > G), MTRNR1 (1555 A > G, 1494 C > T), and GJB3 (538 C > T). The birth condition of infants was also recorded. Results Of 37 573 newborns, 1810 carried pathogenic mutations, or 4.817%. The carrier rates of GJB2 (35 del G, 176 del 16, 235 del C, 299 del AT), GJB3 (538 C > T), SLC26A4 (IVS7-2 A > G, 2168 A > G), and MTRNR1 (1555 A > G, 1494 C > T) mutations were 0.005%, 0.104%, 1.924%, 0.551%, 0.295%, 0.253%, 1.387%, 0.024%, and 0.274%, respectively. Logistic regression analysis indicated no statistically significant relationship between mutations and infant sex, premature delivery, twin status, or birth weight. Conclusions The 235delC GJB2 mutation was the most frequent deafness-related mutation in the Chinese population. Genetic screening for the deafness gene will help detect more cases of newborn congenital HL than current screening practices.

9 June 2024 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
XLXiaodan Li
Xiaodan Li
GZGe Zhang
Ge Zhang
YLYanzhen Li
Yanzhen Li
XZXuexi Zhang
Xuexi Zhang
QLQiaoyin Liu
Qiaoyin Liu
XNXin Ni
Xin Ni
Objectives: The study aims to retrospectively summarize the clinical features of pediatric thyroglossal duct cyst (TGDC), investigate the efficacy of the modified Sistrunk (mSis) procedure, and analyze the recurrence risks. Methods: The clinical data of 391 children with TGDC admitted to Beijing Children’s Hospital affiliated Capital Medical University and Baoding Children’s Hospital from March 2012 to December 2021 were retrospectively analyzed. All patients underwent cervical ultrasound for preoperative evaluation. Twenty cases had magnetic resonance imaging and 8 cases had computed tomography for further evaluation. All patients underwent the standard mSis procedure, and clinical manifestations information, surgical information, complications, and prognosis were analyzed. Results: Among the 391 TGDC cases, 118 (30.2%) had a history of recurrent neck infection and 36 (9.2%) had undergone previous neck cyst and fistula resection surgeries, initially diagnosed as neck cyst (22 cases), TGDC (12 cases), or branchial fistula (2 cases), with only 6 cases having undergone partial hyoid bone resection in the previous operation. During the 15 to 156 months of follow-up, 10 children experienced local wound infection, but no other complications were reported. The recurrence rate was 2.30%, and the recurrence time ranged from 0.5 to 34 (average, 7.2) months post surgery. In the Poisson regression model examining factors related to recurrence, the P values of the 3 factors were <.05: clearness of the lesion boundary, surgical history, and maximum diameter and the relative risk (RR) values corresponding to the 3 risk factors, such as Exp (B), were 27.918, 10.054, and 6.606, respectively. Conclusions: The mSis procedure demonstrated safety and efficacy with fewer complications and a low recurrence rate of 2.30% in the study. Furthermore, the indistinct lesion boundary, surgical history, and large lesion diameter (>2 cm) were independent risk factors for recurrence in pediatric TGDC. Level of Evidence: IV

30 June 2020 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
JHJinsheng Hao
Jinsheng Hao
MCMin Chen
Min Chen
BLBing Liu
Bing Liu
YYYang Yang
Yang Yang
WLWei Liu
Wei Liu
XNXin Ni
Xin Ni
To analyze the clinical characteristics of congenital cholesteatoma (CC), to explore the risk factors related to recurrence of the disease, and to clarify the importance of staging for treatment. A total of 87 patients were followed up for more than 5 years, who had undergone surgical procedures for CC from September 2010 to January 2017 in Beijing Children’s Hospital, Capital Medical University. Patients with CC were identified in accordance with the following Levenson’s criteria. The clinical characteristics of CC on different stage and risk factors related to recurrence of the disease were analyzed. Canal wall up mastoidectomy and tympanoplasty (n = 45), transcanal endoscopic approach (n = 29), and canal wall down mastoidectomy and tympanoplasty (n = 13) was, respectively, performed depending on cholesteatoma extension. Between 2010 and 2013, 20.93% of patients had stage I-II disease, whereas 61.26% had stage I-II disease from 2014 to 2017. Meanwhile, the proportion with stage III-IV disease decreased from 79.07% to 38.64% between these 2 time periods. The preoperative air conduction threshold in patients with stage I, II, III, and IV was, respectively, 23.36 ± 8.20, 45.40 ± 12.82, 47.49 ± 12.03, and 50.37 ± 11.80 dB. The stage of disease was a significant risk factor regarding recurrence (P = .02). Surgery on patients with stage III-IV disease was performed with the aid of a microscope from 2010 to 2013 and with a microscope and endoscope from 2014 to 2017, which reduced the recurrence rate from 26.92% in the former period to 8.33% in the latter period. Early detection of CC is crucial regarding the facilitation of minimally invasive surgery and reducing complication and recurrence rates. The stage of the disease is a significant risk factor regarding recurrence. The surgery shows us the possibility of reducing the recurrence rate of CC, which is performed under a microscope and an endoscope.

18 June 2019 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
JHJinsheng Hao
Jinsheng Hao
MCMin Chen
Min Chen
BLBing Liu
Bing Liu
YYYang Yang
Yang Yang
WLWei Liu
Wei Liu
JZJie Zhang
Jie Zhang